Public Company News
Appian Named a Leader in the IDC MarketScape: Worldwide Business Automation Platforms 2025 Vendor Assessment
MCLEAN, Va., Aug. 26, 2025 /PRNewswire/ -- Appian (NASDAQ: APPN) the leading platform for AI process automation, today announced it has been named a Leader in the IDC MarketScape Worldwide Business Automation Platforms (BAPs) 2025 Vendor Assessment (doc #US52034624,May 2025). According to the ID...
2025-08-26 10:35
1467
BOM BOM Secures Early Stage Investment of SGD$3.5 million to deliver Precision Pet Nutrition in Asia
SINGAPORE, Aug. 26, 2025 /PRNewswire/ -- BOM BOM, the Singapore-based precision pet nutrition company known for its fresh, customised, portioned meals for cats and dogs, has concluded its Series Pre-A round of SGD$3.5 million, led by Blueprint Ventures, a seed stage consumer venture capital firm....
2025-08-26 10:00
2774
MINESEC and NetDragon Partner to Advance Digital Education in Cameroon
HONG KONG, Aug. 26, 2025 /PRNewswire/ -- NetDragon Websoft Holdings Limited ("NetDragon" or "the Company", Hong Kong Stock Code: 0777), a global leader in building internet communities, is pleased to announce that the Ministry of Secondary Education ofCameroon (MINESEC) and NetDragon have entered...
2025-08-26 09:22
4931
High-Trend International Group Announces Regained Compliance With the Minimum Bid Price Requirement of Nasdaq
SIGNAPORE, Aug. 25, 2025 /PRNewswire/ -- High-Trend International Group (the "Registrant" or the "Company") (NASDAQ: HTCO), a global ocean technology company announced that it received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq"), informin...
2025-08-25 21:45
2500
Keep Inc. Announces 2025 Interim Results
BEIJING, Aug. 25, 2025 /PRNewswire/ -- Keep Inc. ("Keep" or the "Company"), the largest online fitness platform inChina, today announced its unaudited interim results for the six months endedJune 30, 2025. First Half 2025 Financial Highlights * Total revenues were RMB821.8 million for the six ...
2025-08-25 21:20
3099
Henlius Keeps Steady Growth in H1 2025: Overseas Product Profits Soar 200%+, Innovation Fuels Global Reach
SHANGHAI, Aug. 25, 2025 /PRNewswire/ -- Henlius (2696.HK) announced its 2025 interim results. In the first half of 2025, Henlius' revenue reached about RMB2.8195 billion, representing an increase of 2.7% YoY. The gross profit of RMB2.1992 billion, up by 10.5% YoY, with a net profit reached RMB390....
2025-08-25 21:18
3483
Lambda Builds AI Factories with Supermicro NVIDIA Blackwell GPU Server Clusters to Deliver Production-ready Next-Gen AI Infrastructure at Scale
* Expanded AI infrastructure with faster results with Supermicro's GPU-optimized servers * Large-scale AI factories for training and inference deployed in record time * Supermicro's advanced liquid-cooling reduces power and cooling costs, enabling energy efficiency and sustainability SAN JOS...
2025-08-25 21:05
2727
Everest Medicines Announces Participation in September Investor Conferences
SHANGHAI, Aug. 25, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced thatIan Woo, President and Chief Fin...
2025-08-25 20:57
1950
Recon Hits Milestone: Chemical Recycling Plant Construction Finished as Project Nears Production Launch
BEIJING, Aug. 25, 2025 /PRNewswire/ -- Recon Technology Ltd. ("Recon" or "the Company"), aChina-based provider of oilfield and low-carbon energy services, announced today that the main manufacturing plant for Shandong Recon Renewable Resources Technology Co., Ltd. ("Shandong Recon")'s 40,000-ton-...
2025-08-25 20:30
3017
Origin Agritech Commences Full-Scale Seed Processing Operations at Xinjiang Production Base
Leveraging Advanced Automation to Support the National Agricultural Supply Chain BEIJING, Aug. 25, 2025 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced that its Xinjiang production and processing f...
2025-08-25 20:00
2339
Peijia Medical Announces 2025 Interim Results
HONG KONG, Aug. 25, 2025 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced financial results for the six months endedJune 30, 2025 ("the Reporting Period") on August 22...
2025-08-25 20:00
3267
Maoyan Entertainment Announces 2025 Interim Results
BEIJING, Aug. 25, 2025 /PRNewswire/ -- Maoyan Entertainment ("Maoyan" or the "Company", 1896.HK), a leading platform providing innovative Internet empowered entertainment services inChina, today announced its audited consolidated results for the six months endedJune 30, 2025. First Half 2025 Fin...
2025-08-25 19:04
2999
HUYA Inc. Announces Strategic Partnership with Kingsoft Shiyou to Co-Publish Goose Goose Duck Mobile in Chinese Mainland
GUANGZHOU, China, Aug. 25, 2025 /PRNewswire/ -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading game-related entertainment and services provider, today announced a strategic partnership with Kingsoft Shiyou to co-publish the popular social deduction game,Goose Goose Duck mobile versio...
2025-08-25 18:30
1985
Acceleration in Clinical Development! Leads Biolabs' LBL-034 Dosed First Patient in Phase Ⅱ Trial
NANJING, China, Aug. 25, 2025 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced the first patient has been successfully dosed in the Phase Ⅱ trial of LBL-034 (GPRC5D/CD3 BsAb) following strong Phase Ⅰ data.This milestone endows...
2025-08-25 18:27
2414
Potential Listing of China Yuchai's Subsidiary
SINGAPORE, Aug. 25, 2025 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company"), wishes to announce that one of its indirect subsidiaries is considering a potential listing (the "Potential Listing Subsidiary") on a foreign stock exchange (the "Potential L...
2025-08-25 18:09
4135
New mtu Series 2000 High Horsepower Engines Produced by MTU Yuchai Power Launched
SINGAPORE, Aug. 25, 2025 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company"), one of the largest powertrain solution manufacturers through its main operating subsidiary inChina, Guangxi Yuchai Machinery Company Limited ("Yuchai"), announced that MTU Yu...
2025-08-25 18:00
3407
Epicsoft Asia Completes Compulsory Acquisition and Delisting of Ban Leong Technologies Limited
SINGAPORE, Aug. 25, 2025 /PRNewswire/ -- Epicsoft Asia Pte. Ltd. ("Epicsoft Asia" or "Offeror"), an indirect subsidiary of GCL Global Holdings Ltd ("GCL") (NASDAQ: GCL), today announced it has completed the compulsory acquisition of Ban Leong Technologies Limited ("Ban Leong") on August 25, 2025,...
2025-08-25 17:30
2792
Lundbeck to present new data on bexicaserin at upcoming congress, highlighting long-term impact on seizure frequency in patients with rare epilepsy
* The full results of the open label extension (OLE) of the Phase 1b/2a PACIFIC trial investigating bexicaserin for the treatment of patients with Developmental and Epileptic Encephalopathies (DEEs), will be presented for the first time at the International Epilepsy Annual Congress1 * DEEs ar...
2025-08-25 15:43
1457
Galan Lithium Limited: SUCCESSFUL DUE DILIGENCE COMPLETED - $20M PLACEMENT TO PROCEED
Highlights: * All conditions in relation to the $20 million placement to Clean Elements Fund have been satisfied. * Due diligence undertaken by Clean Elements Fund validates the standing of Hombre Muerto West (HMW) as a world class lithium project, offering exceptional scale and grade. * G...
2025-08-25 15:32
2347
Akeso Reports Phase 3 Trials Show Positive Results: Gumokimab (IL-17) for Ankylosing Spondylitis and Manfidokimab (IL-4Rα) for Atopic Dermatitis Achieve Primary Endpoints
HONG KONG, Aug. 25, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) ("Akeso" or "the Company") today announced positive results from its Phase 3 clinical trial of gumokimab (AK111), a novel, fully human anti-IL-17A monoclonal antibody, for the treatment of active ankylosing spondylitis (AS). The study ...
2025-08-25 13:46
1673
Week's Top Stories
Most Reposted
Agoda Opens New Office at One Bangkok, Enhancing Its Technology Hub in Thailand
[Picked up by 319 media titles]
2026-04-09 13:00
Visa Opens the Door to AI-Driven Shopping for Businesses Worldwide
[Picked up by 312 media titles]
2026-04-09 09:00Sustainable Tourism Impact Fund Expands Investments Across Southeast Asia
[Picked up by 309 media titles]
2026-04-03 11:30
Visa cements global K-pop connection as Worldwide Tour Sponsor for "BTS WORLD TOUR 'ARIRANG'"
[Picked up by 307 media titles]
2026-04-06 10:00
UTP Advances Across Key Disciplines in QS World University Rankings By Subject 2026 - Petroleum Engineering Among World's Top 10
[Picked up by 298 media titles]
2026-04-06 16:46
Most Read
Korea's Supreme Court Upholds Korea Zinc's Voting Restriction, Rebuffing Young Poong's Legal Challenge
2026-04-03 21:00
5895
51Talk Marks 15 Years with Global Brand Refresh and Names Thai Actor, Shahkrit Yamnarm as Brand Ambassador in Thailand
2026-04-03 11:00
5642
Xinhua Silk Road: Global South financiers visit E. China's Ningbo to explore industrial and cultural innovation
2026-04-03 20:02
5338
Ridgetech, Inc. Announces 1-for-150 Reverse Share Split
2026-04-04 00:00
5105
